AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3251510 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 6
Study 3251510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 11120898 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced sputum (3% NaCl, 20 minutes)
Number of subjects: 20
Study 31350828 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive antihypertensive treatment (100 mg urapidil and 30 mL of 0.9% sodium chloride after initial 25 mg urapidil injection)
Number of subjects: 121
Study 31350828 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive antihypertensive treatment
Number of subjects: 121
Study 31350828 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 mg urapidil injection)
Number of subjects: 121
Study 31350828 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study 29322620 — intervention group
Group type: EXPERIMENTAL
Intervention: Spent hops-rice protein matrix preparation
Number of subjects: 6
Study 29322620 — intervention group
Group type: COMPARATOR
Intervention: Control spent hops preparation
Number of subjects: 6
Study 26597151 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose lipopolysaccharide (LPS) 0.4 ng/kg
Number of subjects: 45
Study 26597151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 24652018 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-retaining barbed sutures (SRBS)
Number of subjects: 50
Study 24652018 — intervention group
Group type: COMPARATOR
Intervention: Conventional sutures
Number of subjects: 50
Study 22703720 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion‐recognition‐training (ERT)
Number of subjects: 195
Study 22703720 — intervention group
Group type: COMPARATOR
Intervention: Treatment‐as‐usual (TAU)
Number of subjects: 195
Study 21156883 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin initiation
Number of subjects: 379
Study 21156883 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 379
Study 21156883 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant use of oral antihyperglycemic agents
Number of subjects: 379
Study 21156883 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea use
Number of subjects: 379
Study 17389205 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical papaverine application at room temperature
Number of subjects: 120
Study 17389205 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical heated papaverine (at 37 degrees C) application
Number of subjects: 120
Study 17389205 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal thoracic artery pedicle storage in normothermic conditions
Number of subjects: 120
Study 17389205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicle storage in normothermic conditions combined with topical papaverine application
Number of subjects: 120
Study 17389205 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedicle storage in normothermic conditions combined with topical heated papaverine application
Number of subjects: 120
Study 17389205 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment, stored at room temperature)
Number of subjects: 120
Study 15647189 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic therapy (Bifidobacterium longum/Synergy 1)
Number of subjects: 18
Study 15647189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12390566 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically active toothbrush
Number of subjects: 66
Study 12390566 — intervention group
Group type: COMPARATOR
Intervention: Control brush (Butler GUM 309)
Number of subjects: 66
Study 9950310 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression model (MR)
Number of subjects: 2144
Study 9950310 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial neural network (ANN)
Number of subjects: 2144
Study 7598144 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR positive patients (n=14 of 76, 18.4%)
Number of subjects: 105
Study 7598144 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with systemic symptoms (n=33)
Number of subjects: 105
Study 7598144 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with multiple skin lesions (n=16)
Number of subjects: 105
Study 7598144 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a higher total number of symptoms (median 2.5 in PCR-positive patients)
Number of subjects: 105
Study 7598144 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic patients with single erythema migrans lesions (n=42)
Number of subjects: 105
Study 7598144 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall PCR detection of Borrelia burgdorferi
Number of subjects: 105
Study 2090821 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency TNS (100 Hz)
Number of subjects: 19
Study 2090821 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency TNS (2 Hz)
Number of subjects: 19
Study 2090821 — intervention group
Group type: COMPARATOR
Intervention: Placebo TNS
Number of subjects: 19
Study 835319 — intervention group
Group type: EXPERIMENTAL
Intervention: Early mobilisation programme (B)
Number of subjects: 200
Study 835319 — intervention group
Group type: COMPARATOR
Intervention: Conventional mobilisation (A)
Number of subjects: 200
Study 30497110 — intervention group
Group type: EXPERIMENTAL
Intervention: Data submitted by the treating surgeon for peer review
Number of subjects: 629
Study 30497110 — intervention group
Group type: EXPERIMENTAL
Intervention: Thromboembolism deterrent stockings
Number of subjects: 629
Study 28215136 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic prevention and treatment of fever
Number of subjects: 184
Study 28215136 — intervention group
Group type: COMPARATOR
Intervention: Standard temperature management
Number of subjects: 184
Study 25761434 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg subcutaneously every 6 months)
Number of subjects: 42
Study 25761434 — intervention group
Group type: COMPARATOR
Intervention: Oral bisphosphonates
Number of subjects: 42
Study 25761434 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 42
Study 24311451 — intervention group
Group type: EXPERIMENTAL
Intervention: Big breakfast (BB) rich in fat and protein providing 33% of total daily energy
Number of subjects: 59
Study 24311451 — intervention group
Group type: COMPARATOR
Intervention: Small breakfast (SB) rich in carbohydrates providing 12.5% of total daily energy
Number of subjects: 59
Study 22445437 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring delivering Nestorone and ethinyl estradiol (EE)
Number of subjects: 0
Study 22445437 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive containing levonorgestrel and EE
Number of subjects: 0
Study 19164772 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (8 x 5 leg extension, 80% 1 repetition maximum) followed by endurance exercise (30 min cycling, 70% Vo2peak)
Number of subjects: 8
Study 19164772 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise (30 min cycling, 70% Vo2peak) followed by resistance exercise (8 x 5 leg extension, 80% 1 repetition maximum)
Number of subjects: 8
Study 17721294 — intervention group
Group type: EXPERIMENTAL
Intervention: Systane Lubricant Eye Drops
Number of subjects: 50
Study 17721294 — intervention group
Group type: COMPARATOR
Intervention: Refresh Tears
Number of subjects: 50
Study 17721294 — intervention group
Group type: COMPARATOR
Intervention: Refresh Endura
Number of subjects: 50
Study 14969377 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue Scraping
Number of subjects: 60
Study 14969377 — intervention group
Group type: EXPERIMENTAL
Intervention: Listerine Oral Care Strip
Number of subjects: 60
Study 14969377 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated Saline Solution
Number of subjects: 60
Study 15373008 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumferential ankle pressure (CAP) applied using a pediatric blood pressure cuff.
Number of subjects: 10
Study 15373008 — intervention group
Group type: COMPARATOR
Intervention: Circumferential ankle pressure (CAP) applied.
Number of subjects: 10
Study 11159485 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepared strip containing 1.3 microl of 0.5% fluorescein
Number of subjects: 168
Study 11159485 — intervention group
Group type: COMPARATOR
Intervention: Standard method of performing the TFI with and without topical anaesthetic
Number of subjects: 168
Study 9196673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nearpoint condition
Number of subjects: 16
Study 9196673 — intervention group
Group type: EXPERIMENTAL
Intervention: Farpoint condition
Number of subjects: 16
Study 8195578 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 106
Study 8195578 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 106
Study 2905879 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 25 mg twice daily
Number of subjects: 10
Study 2905879 — intervention group
Group type: EXPERIMENTAL
Intervention: Bopindolol 1 mg daily
Number of subjects: 10
Study 31642513 — intervention group
Group type: EXPERIMENTAL
Intervention: FAUCS
Number of subjects: 112
Study 31642513 — intervention group
Group type: COMPARATOR
Intervention: MLC
Number of subjects: 112
Study 29314597 — intervention group
Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir and dasabuvir regimen (ribavirin-free)
Number of subjects: 0
Study 29314597 — intervention group
Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir and dasabuvir + ribavirin
Number of subjects: 0
Study 29314597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29314597 — intervention group
Group type: EXPERIMENTAL
Intervention: ombitasvir/paritaprevir/ritonavir and dasabuvir (ribavirin-free)
Number of subjects: 0
Study 29314597 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype 1b patients
Number of subjects: 0
Study 29314597 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype 1a patients
Number of subjects: 0
Study 28851789 — intervention group
Group type: EXPERIMENTAL
Intervention: Real stimulation with theta burst stimulation (TBS) of the contralesional primary motor cortex
Number of subjects: 60
Study 28851789 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study 26315876 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (50 mg/kg)
Number of subjects: 110
Study 26315876 — intervention group
Group type: COMPARATOR
Intervention: Control (rocuronium 0.6 mg/kg)
Number of subjects: 110
Study 26315876 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 110
Study 26315876 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium prime (0.06 mg/kg rocuronium 3 minutes before 0.54 mg/kg rocuronium)
Number of subjects: 110
Study 26315876 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 0.9 (0.9 mg/kg)
Number of subjects: 110
Study 26315876 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium prime group
Number of subjects: 110
Study 23219385 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD7009
Number of subjects: 8
Study 23219385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 21241263 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 IU of oxytocin during surgical procedure
Number of subjects: 378
Study 21241263 — intervention group
Group type: COMPARATOR
Intervention: No oxytocic agent (control group)
Number of subjects: 378
Study 18278988 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute bilateral electroconvulsive therapy (ECT)
Number of subjects: 489
Study 17103080 — intervention group
Group type: EXPERIMENTAL
Intervention: Hempseed oil (HO) 30 ml/day for 4 weeks
Number of subjects: 14
Study 17103080 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (FO) 30 ml/day for 4 weeks
Number of subjects: 14
Study 12924534 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized zanamivir (16 mg four times a day) plus rimantadine
Number of subjects: 41
Study 12924534 — intervention group
Group type: COMPARATOR
Intervention: Rimantadine with nebulized saline (Control)
Number of subjects: 41
Study 12924534 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized zanamivir plus rimantadine
Number of subjects: 41
Study 11070372 — intervention group
Group type: EXPERIMENTAL
Intervention: sipatrigine (10, 18, 27, or 36 mg/kg by continuous intravenous infusion over 65 hours)
Number of subjects: 27
Study 11070372 — intervention group
Group type: EXPERIMENTAL
Intervention: sipatrigine
Number of subjects: 27
Study 11070372 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 8622153 — intervention group
Group type: EXPERIMENTAL
Intervention: AVS (4 g, infused intravenously for 6-8 hours once a day for 10 to 14 days)
Number of subjects: 162
Study 8622153 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 g glucose, infused intravenously for 6-8 hours once a day for 10 to 14 days)
Number of subjects: 162
Study 1567268 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentian violet mouth washes (1.5 ml 0.5% aqueous solution b.i.d.)
Number of subjects: 141
Study 1567268 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketoconazole (200 mg/day, after a meal)
Number of subjects: 141
Study 1567268 — intervention group
Group type: EXPERIMENTAL
Intervention: Nystatin mouth washes (200,000 U oral suspension q.i.d.)
Number of subjects: 141
Study 4056079 — intervention group
Group type: EXPERIMENTAL
Intervention: Respbid
Number of subjects: 19
Study 4056079 — intervention group
Group type: EXPERIMENTAL
Intervention: Theo-Dur
Number of subjects: 19
Study 4056079 — intervention group
Group type: COMPARATOR
Intervention: Intravenous aminophylline
Number of subjects: 19
Study 31354252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-anchored annular closure device (ACD)
Number of subjects: 550
Study 31354252 — intervention group
Group type: COMPARATOR
Intervention: No additional implantation (controls)
Number of subjects: 550
Study 28652064 — intervention group
Group type: EXPERIMENTAL
Intervention: External Focus (EF)
Number of subjects: 33
Study 28652064 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Focus (IF)
Number of subjects: 33
Study 28652064 — intervention group
Group type: EXPERIMENTAL
Intervention: Fugl‐Meyer Assessment
Number of subjects: 33
Study 28652064 — intervention group
Group type: EXPERIMENTAL
Intervention: Wolf Motor Function Test
Number of subjects: 33
Study 27140710 — intervention group
Group type: EXPERIMENTAL
Intervention: somatostatin + ulinastatin
Number of subjects: 492
Study 27140710 — intervention group
Group type: EXPERIMENTAL
Intervention: somatostatin + gabexate
Number of subjects: 492
Study 27140710 — intervention group
Group type: EXPERIMENTAL
Intervention: somatostatin + ulinastatin + gabexate
Number of subjects: 492
Study 27140710 — intervention group
Group type: COMPARATOR
Intervention: somatostatin
Number of subjects: 492
Study 24438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplement of 40 mg/d
Number of subjects: 878
Study 24438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplement of 80 mg/d
Number of subjects: 878
Study 24438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplement of 20 mg/d
Number of subjects: 878
Study 24438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplement of 40 mg/d (Stratum #1)
Number of subjects: 878
Study 24438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplement of 40 mg/d (Stratum #2)
Number of subjects: 878
Study 22710812 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative infusion of 18 compound amino acids (group AA)
Number of subjects: 36
Study 22710812 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer solution (group LR)
Number of subjects: 36
Study 19436119 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 2 g/kg for 1 day
Number of subjects: 62
Study 19436119 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 1 g/kg for 1 day
Number of subjects: 62
Study 19436119 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG 400 mg/kg/day for 5 days
Number of subjects: 62
Study 19436119 — intervention group
Group type: COMPARATOR
Intervention: No IVIG administration
Number of subjects: 62
Study 17616008 — intervention group
Group type: EXPERIMENTAL
Intervention: PureSorb-Q40 (P40)
Number of subjects: 0
Study 17616008 — intervention group
Group type: COMPARATOR
Intervention: Lipid-soluble CoQ10
Number of subjects: 0
Study 15621905 — intervention group
Group type: EXPERIMENTAL
Intervention: Metallic staples
Number of subjects: 0
Study 15621905 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular vicryl suture
Number of subjects: 0
Study 11936563 — intervention group
Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg
Number of subjects: 0
Study 11936563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10431402 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of the prostate (TVP)
Number of subjects: 40
Study 10431402 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 40
Study 8771231 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (3 mg/h)
Number of subjects: 12
Study 8771231 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study 2170104 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant bean flakes (174 g/d)
Number of subjects: 7
Study 2170104 — intervention group
Group type: COMPARATOR
Intervention: Potato flakes (102 g/d)
Number of subjects: 7
Study 2170104 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant bean flakes (40 g starch)
Number of subjects: 7
Study 2170104 — intervention group
Group type: COMPARATOR
Intervention: Potato flakes (40 g starch)
Number of subjects: 7
Study 6154562 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 0
Study 6154562 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES)
Number of subjects: 0
Study 6154562 — intervention group
Group type: COMPARATOR
Intervention: Control (preinfusion values)
Number of subjects: 0
Study 6389484 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release theophylline preparation U (Uniphyl tablets) once daily, 800 mg
Number of subjects: 0
Study 6389484 — intervention group
Group type: COMPARATOR
Intervention: Controlled-release theophylline T-D (Theo-Dur tablets) administered 12-hourly, 800 mg
Number of subjects: 0
Study 30303904 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (70% nitrous/30% oxygen)
Number of subjects: 39
Study 30303904 — intervention group
Group type: COMPARATOR
Intervention: IV sedation (100 micrograms fentanyl and 2 mg midazolam)
Number of subjects: 39
Study 26783318 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous rt-PA (alteplase)
Number of subjects: 0
Study 26783318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25303029 — intervention group
Group type: COMPARATOR
Intervention: Viscous fiber blend (VFB) mixed with margarine
Number of subjects: 25
Study 25303029 — intervention group
Group type: COMPARATOR
Intervention: Viscous fiber blend (VFB) baked into white bread
Number of subjects: 25
Study 25303029 — intervention group
Group type: COMPARATOR
Intervention: Capsules containing VFB
Number of subjects: 25
Study 25303029 — intervention group
Group type: COMPARATOR
Intervention: Control (no VFB)
Number of subjects: 25
Study 22760386 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M DuraPrep Surgical Solution Patient Preoperative Skin Preparation
Number of subjects: 22
Study 22760386 — intervention group
Group type: COMPARATOR
Intervention: ChloraPrep with Tint (Scrub Teal) Patient Preoperative Skin Preparation
Number of subjects: 22
Study 20975106 — intervention group
Group type: EXPERIMENTAL
Intervention: Silica-based mineral antioxidant complex (MAC) supplementation
Number of subjects: 0
Study 20975106 — intervention group
Group type: COMPARATOR
Intervention: Rice flour (placebo)
Number of subjects: 0
Study 20975106 — intervention group
Group type: COMPARATOR
Intervention: Water only (baseline)
Number of subjects: 0
Study 17914062 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0974 300 mg
Number of subjects: 272
Study 17914062 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0974 400 mg
Number of subjects: 272
Study 17914062 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0974 600 mg
Number of subjects: 272
Study 17914062 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 272
Study 17914062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study 15365138 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (n = 214)
Number of subjects: 323
Study 15365138 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 109)
Number of subjects: 323
Study 11302269 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 0
Study 11302269 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 11302269 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 11302269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9385350 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cladribine (2‐CdA) at a dosage of 0.05 mg/kg subcutaneously weekly for 8 weeks
Number of subjects: 5
Study 8174421 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (N = 15)
Number of subjects: 77
Study 8174421 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxicam (N = 36)
Number of subjects: 77
Study 8174421 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 26)
Number of subjects: 77
Study 2975949 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (n = 56)
Number of subjects: 110
Study 2975949 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 54)
Number of subjects: 110
Study 29735215 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF dispersible tablets (MMFdt)
Number of subjects: 40
Study 29735215 — intervention group
Group type: COMPARATOR
Intervention: MMF capsules (MMFc)
Number of subjects: 40
Study 26390408 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified user guide
Number of subjects: 89
Study 26390408 — intervention group
Group type: COMPARATOR
Intervention: Original user guide
Number of subjects: 89
Study 24740408 — intervention group
Group type: EXPERIMENTAL
Intervention: Portex Group (bevel facing left)
Number of subjects: 200